Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Stability & shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency.

560 FDA drug recalls with this cause, newest first.

These recalls involve products whose stability data no longer supports the expiry date on the label, or that failed a stability test before that date. A medicine that loses potency early does not just stop working as well; it can also change chemically into something FDA never approved. The fix is usually a shorter shelf life for future lots.

Class II · Moderate risk

Buffered Lidocaine

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0028-2017
Class II · Moderate risk

Buffered Lidocaine

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0027-2017
Class II · Moderate risk

atropine Sulfate Injection

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0026-2017
Class II · Moderate risk

atropine Sulfate Injection

Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.

Terminated Stability / shelf life Pharmedium Services, LLC D-0025-2017
Class III · Low risk

Foradil Aerolizer

Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.

Terminated Stability / shelf life Novartis Pharmaceuticals Corp. D-1138-2015
Class III · Low risk

Foradil Aerolizer

Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.

Terminated Stability / shelf life Novartis Pharmaceuticals Corp. D-1137-2015
Class II · Moderate risk

Alinia (nitazoxanide)

Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity

Terminated Stability / shelf life Romark Laboratories, L.C. D-0983-2015
Class I · High risk

MitoXANTRONE Injection

Failed Stability Specifications: Product is subpotent and has out of specification known and unknown impurities.

Terminated Stability / shelf life Hospira Inc. D-0433-2015
Class II · Moderate risk

Ticarcillin Sodium/Potassium Clavulanate

Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.

Terminated Stability / shelf life Attix Pharmaceuticals D-929-2015
Class II · Moderate risk

Glimepiride Tablets

Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.

Terminated Stability / shelf life Micro Labs Usa, Inc S NDC 42571-101-01 D-0046-2015
Class II · Moderate risk

Ketorolac Tromethamine INJECTION

Incorrect or Missing Lot and/or Exp Date: Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration date.

Terminated Stability / shelf life Sagent Pharmaceuticals Inc NDC 25021-701-01 D-0027-2015
Class II · Moderate risk

Fluocinonide Gel USP

Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>.

Terminated Stability / shelf life Fougera Pharmaceuticals Inc. NDC 0168-0135-15 D-0245-2015
Class III · Low risk

Foradil Aerolizer

Failed Stability Specification; out of specification result for particle size distribution during stability testing

Terminated Stability / shelf life Novartis Pharmaceuticals Corp. NDC 0085-1401-01 D-1387-2014
Class III · Low risk

Glytone Acne

Failed Stability Specifications: Out of specification results for viscosity in one lot of Glytone Acne Treatment Facial Cleanser.

Terminated Stability / shelf life Genesis Pharmaceutical, Inc. D-1285-2014
Class III · Low risk

Acyclovir Oral Suspension

Failed Stability Specification; product viscosity and or pH are below specification.

Terminated Stability / shelf life Hi-Tech Pharmacal Co., Inc. NDC 50383-810-16 D-389-2014